ArticleBreast cancer research : BCR2019

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.

Dong-Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.